Dance/movement therapy for improving balance ability and bone mineral density in long-term patients with schizophrenia: a randomized controlled trial.


Journal

Schizophrenia (Heidelberg, Germany)
ISSN: 2754-6993
Titre abrégé: Schizophrenia (Heidelb)
Pays: Germany
ID NLM: 9918367987006676

Informations de publication

Date de publication:
31 Jul 2023
Historique:
received: 22 03 2023
accepted: 26 06 2023
medline: 1 8 2023
pubmed: 1 8 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Fractures are common accidents for long-term hospitalized patients with schizophrenia (SZ) in psychiatric hospitals, and once they occur, patients usually endure the pain of fractures for a long time. Accumulating evidence has supported the implementation of dance/movement therapy (DMT) as a promising intervention for patients with SZ. However, no research has been conducted to investigate its role in balance ability in SZ. This study was designed to investigate the efficacy of a 12-week DMT intervention in bone mineral density and balance ability in patients with SZ using a randomized, controlled trial design. A total of 58 veterans with SZ were randomly assigned to the DMT intervention group (n = 29) and the treatment-as-usual (TAU) group (n = 29). Bone mineral density (BMD) and balance ability were measured in both groups at two measurement points (at baseline and at the end of Week 12). We found that patients in the DMT intervention group had significant improvements in BMD and balance ability compared with the TAU group by using repeated measures analysis of variance. Treatment with DMT demonstrated a significant improvement in BMD from baseline to week 12 (0.03, 95% CI: 0.01-0.05). For the Berg total score and static and dynamic balance, the mean changes in the DMT group were 7.3 (95% CI: 5.6-9.0), 4.0 (95% CI: 0.9-7.1), and 3.7 (95% CI: 2.6-4.8), respectively. Regression analysis showed that baseline BMD was a significant predictor of improvement in BMD from baseline to week 12 in the DMT group (β = 0.58, p < 0.001). Our results suggest for the first time that DMT intervention may be effective in beneficially regulating BMD and balance ability in SZ patients.

Identifiants

pubmed: 37524713
doi: 10.1038/s41537-023-00373-w
pii: 10.1038/s41537-023-00373-w
pmc: PMC10390548
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47

Informations de copyright

© 2023. The Author(s).

Références

Eur Neuropsychopharmacol. 2013 Aug;23(8):872-8
pubmed: 23642346
Qual Saf Health Care. 2008 Dec;17(6):424-30
pubmed: 19064657
Mil Med Res. 2022 Oct 18;9(1):59
pubmed: 36253804
Curr Opin Psychiatry. 2012 Sep;25(5):415-29
pubmed: 22744405
Expert Opin Drug Saf. 2016 Jun;15(6):809-23
pubmed: 26986209
Epidemiology. 2010 Sep;21(5):658-68
pubmed: 20585256
Schizophr Res. 2005 Dec 15;80(2-3):213-25
pubmed: 16137859
Psychopharmacology (Berl). 2006 Jul;186(4):572-8
pubmed: 16601995
Phys Ther. 2007 Sep;87(9):1155-63
pubmed: 17636155
Mol Psychiatry. 2008 Jan;13(1):27-35
pubmed: 17848919
Psychol Med. 2006 May;36(5):669-78
pubmed: 16608559
JAMA Psychiatry. 2020 Feb 1;77(2):201-210
pubmed: 31664453
Front Psychol. 2021 Jul 15;12:678397
pubmed: 34366998
J Nerv Ment Dis. 2021 Feb 1;209(2):114-122
pubmed: 33141785
Appl Health Econ Health Policy. 2023 Mar;21(2):315-325
pubmed: 36494574
Br J Psychiatry. 2014 Feb;204(2):164
pubmed: 24493657
P T. 2018 Feb;43(2):92-104
pubmed: 29386866
World Health Organ Tech Rep Ser. 1994;843:1-129
pubmed: 7941614
Front Aging Neurosci. 2022 Aug 08;14:975711
pubmed: 36004000
Psychoneuroendocrinology. 2018 Feb;88:54-60
pubmed: 29175720
Psychosom Med. 1995 Sep-Oct;57(5):485-91
pubmed: 8552740
Acta Psychiatr Scand. 2014 Dec;130(6):470-86
pubmed: 25041606
Eur J Orthop Surg Traumatol. 2023 Apr;33(3):473-479
pubmed: 36527505
Curr Osteoporos Rep. 2016 Dec;14(6):249-259
pubmed: 27696144
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006868
pubmed: 19160306
J Am Geriatr Soc. 2008 Dec;56(12):2234-43
pubmed: 19093923
Schizophr Res. 2018 Nov;201:70-78
pubmed: 29793816
Br J Clin Pharmacol. 2010 May;69(5):535-42
pubmed: 20573090
Psychiatry Res. 2013 May 15;207(1-2):25-32
pubmed: 23051886
Br J Psychiatry. 2004 Jun;184:503-8
pubmed: 15172944
Health Technol Assess. 2016 Feb;20(11):vii-xxiii, 1-100
pubmed: 26869182
Gen Hosp Psychiatry. 2015 Mar-Apr;37(2):126-33
pubmed: 25666994
Front Mol Neurosci. 2019 Feb 12;12:1
pubmed: 30809121
Clin Geriatr Med. 2010 Nov;26(4):645-92
pubmed: 20934615
BMC Health Serv Res. 2006 Jun 07;6:69
pubmed: 16759386
Sci Rep. 2017 Mar 22;7:45203
pubmed: 28327672
J Bone Miner Res. 1994 Aug;9(8):1137-41
pubmed: 7976495
Neurol Clin. 2011 Feb;29(1):127-48, viii
pubmed: 21172575
J Psychiatr Res. 2021 Feb;134:39-47
pubmed: 33360223
Lancet. 2018 Feb 17;391(10121):648
pubmed: 29617256
Clin Psychol Psychother. 2021 Jan;28(1):24-38
pubmed: 32539160
BMJ Open. 2021 Aug 9;11(8):e051173
pubmed: 34373313
Schizophr Res. 2018 May;195:488-494
pubmed: 29056492
Lancet Psychiatry. 2020 Jan;7(1):64-77
pubmed: 31860457
Clin Med (Lond). 2014 Apr;14(2):187-91
pubmed: 24715132
Int J Ment Health Nurs. 2019 Apr;28(2):457-467
pubmed: 30294958
J Ment Health. 2022 Oct;31(5):613-623
pubmed: 32401072

Auteurs

Hengyong Guan (H)

Hebei Province Veterans Hospital, Hebei, China.

Zhaoxia Zhou (Z)

Hebei Province Veterans Hospital, Hebei, China.

Xipo Li (X)

Hebei Province Veterans Hospital, Hebei, China.

Yanfen Pan (Y)

Hebei Province Veterans Hospital, Hebei, China.

Zhenmin Zou (Z)

Hebei Province Veterans Hospital, Hebei, China.

Xiangfei Meng (X)

Hebei Province Veterans Hospital, Hebei, China.

Kunya Guan (K)

Hebei Province Veterans Hospital, Hebei, China.

Lie Zhang (L)

Hebei Province Veterans Hospital, Hebei, China.

Zhanmin Li (Z)

Hebei Province Veterans Hospital, Hebei, China.

Xueling Li (X)

Hebei Province Veterans Hospital, Hebei, China.

Baochun Wei (B)

Hebei Province Veterans Hospital, Hebei, China.

Xuan Zhang (X)

Hebei Province Veterans Hospital, Hebei, China.

Weiqing Li (W)

Hebei Province Veterans Hospital, Hebei, China.

Dongmei Han (D)

Hebei Province Veterans Hospital, Hebei, China.

Zezhi Li (Z)

Department of Nutritional and Metabolic Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.
Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China Guangzhou Medical University, Guangzhou, China.

Meihong Xiu (M)

Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, China. xiumeihong97@163.com.

Classifications MeSH